Paid Clinical Trials Columbus
Discover 1,205 paid clinical trials in Columbus, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
LumateperoneMulticenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Sponsor:
Intra-Cellular Therapies, Inc.
Location:
Code:
NCT06372964
Conditions
Bipolar Depression
Eligibility Criteria
Sex: All
Age: 10 - 17
Healthy Volunteers: Not accepted
Interventions
Lumateperone
Placebo
Observational StudyPancreatic Cancer Early Detection Consortium
Sponsor:
Arbor Research Collaborative for Health
Location:
Code:
NCT04970056
Conditions
Pancreas Cancer
Pancreas Cyst
Pancreatic Ductal Adenocarcinoma
Genetic Predisposition
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Elotuzumab, CC-92480, DexamethasoneElotuzumab, CC-92480, and Dexamethasone for the Treatment of Relapsed or Refractory Myeloma After CD38- and BCMA-Targeted Therapies
Sponsor:
Abdullah Khan
Location:
Code:
NCT05981209
Conditions
Recurrent Multiple Myeloma
Refractory Multiple Myeloma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Bone Marrow Aspiration
Bone Marrow Biopsy
Computed Tomography
Dexamethasone
CPAP TherapyEffects of CPAP Therapy on Blood Pressure and Heart Rate Variability in Obstructive Sleep Apnea
Sponsor:
Ohio State University
Location:
Code:
NCT04712656
Conditions
Sleep Apnea, Obstructive
Eligibility Criteria
Sex: All
Age: 30 - 70+
Healthy Volunteers: Not accepted
Interventions
CPAP therapy
FT825/ONO-8250 & Monoclonal AntibodiesFT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors
Sponsor:
Fate Therapeutics
Location:
Code:
NCT06241456
Conditions
Advanced Solid Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
FT825
Fludarabine
Cyclophosphamide
Bendamustine
Docetaxel
Interested in new trials?
Get alerts for new trials in your area by subscribing now
AI-081Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors
Sponsor:
OncoC4, Inc.
Location:
Code:
NCT06635785
Conditions
Advanced Solid Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
AI-081
Alisertib & Endocrine TherapyA Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Sponsor:
Puma Biotechnology, Inc.
Location:
Code:
NCT06369285
Conditions
Hormone Receptor Positive HER-2 Negative Breast Cancer
Metastatic Breast Cancer
Recurrent Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Alisertib
Endocrine therapy
OfatumumabPharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT06869785
Conditions
Relapsing Multiple Sclerosis (RMS)
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Ofatumumab approved dose
Ofatumumab new dose
Genetic RegistryParkinson's Foundation PD GENEration Genetic Registry
Sponsor:
Parkinson's Foundation
Location:
Code:
NCT04994015
Conditions
Parkinson's Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Lab Assay for seven genetic variants for Parkinson's Disease
Thrombectomy PlatformStrokeNet Thrombectomy Endovascular Platform
Sponsor:
Medical University of South Carolina
Location:
Code:
NCT06289985
Conditions
Ischemic Stroke
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Endovascular thrombectomy with any FDA-approved category POL or NRY device
Medical Management